Bethesda 2001报告在妇科细胞学筛查中的应用  

Application of the Bethesda system 2001 report in gynecological cytologic screening

作　　者：韩淑梅[1] 李春洪[1] 冯丽华[1] 王红 周那[3] 

机构地区：[1]吉林大学第一医院妇产科,吉林长春130021 [2]西藏自治区林芝地区人民医院妇产科,西藏林芝860000 [3]吉林大学第一医院儿外科,吉林长春130021

出　　处：《中国实验诊断学》2006年第9期1058-1059,共2页Chinese Journal of Laboratory Diagnosis

基　　金：吉林省科技厅基金资助项目(20030538-5)

摘　　要：目的探讨Bethesda 2001报告在妇科细胞学筛查中应用的价值。方法应用利普液基细胞学制片技术结合Bethesda 2001报告作为妇科细胞学筛查方法。结果2065例患者取材满意的标本2060例(占99.76%),不满意要求重新取材的标本5例(占0.24%)。检出真菌71例(占3.43%),阴道毛滴虫31例(占1.50%),加德纳菌79例(占3.83%),人乳头瘤病毒42例(占2.03%)。NILM 1995例(占94.67%),ASC-US 24例(占1.16%),ASC-H 12例(占0.58%),LSIL 45例(占2.18%),HSIL 24例(占1.16%),宫颈鳞癌5例(占0.24%)。结论利普液基细胞学制片技术在取材和制片都有所改进,提高了早期宫颈癌及癌前病变的检出率。Bethesda 2001描述性报告内容广泛,具体,更便于临床医师和实验室交流,在妇科细胞学筛查中具有重要意义。Objective To discuss the value of applying the Bethesda system 2001 report in gynecological cytologic screening. Methods Apply Liqui-PREP in gynecological cytologic screening and diagnosed with Bethesda 2001 standard. Results 2060 out of 2065 specimens （99.76%） are satisfactory,the rest 5（0.24%）dissatisfactory cases are required to re-smear,as a result,71 cases epiphyte（oecupying 3.43% ）,31 eases trichomonas vaginalis（1.50%） ,42 eases human pap＇dlomavirus（2.03 % ）are reported.In thoes specimens,there are 1955 eases NILM（94.67% ） ,24 eases ASC-US（1.16% ）, 12 eases ASC-H（0.58% ） ,45 eases LSIL（2.18% ）,24 eases HSIL（1.16% ） ,5 eases squamous cervical epithelial carcinoma（0.24% ）. Condusion Liqui-PREP improves upon both smearing and sheet formatting, increases detectable rate of premature squamous cervical epithelial carcinoma and precancerosis. The descriptively Bethesda system 2001 report has extensive and concrete eonten;helps clinicians communicate wiht the laboratory more expediently, The descriptively Bethesda system 2001 report method has import significance in gynecological cytologic screening,

关 键 词：BETHESDA 2001报告 液基细胞学 筛查 

分 类 号：R446.8[医药卫生—诊断学]